If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

The $1.15 billion innovation hub on UC Davis’ Sacramento campus is expected to drive $500 million in annual economic output ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have received a consensus recommendation of “Moderate Buy” ...

Equities research analysts at Wedbush boosted their FY2028 earnings per share estimates for shares of Chimerix in a research note issued on Tuesday, February 18th. Wedbush analyst D. Nierengarten now ...

Q4 2024 Management View CEO Adam Steensberg emphasized 2024 as a transformational year for Zealand Pharma, highlighting significant clinical advancements in its obesity pipeline, particularly with ...